✦ LIBER ✦

Antithrombotic treatment for the primary prevention of stroke in patients with non valvular atrial fibrillation: A reappraisal of the evidence and network meta analysis

✍ Scribed by Andrew Owen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Warfarin for the prevention of systemic

✍ Andersen, L V; Vestergaard, P; Deichgraeber, P; Lindholt, J S; Mortensen, L S; F 📂 Article 📅 2008 🏛 BMJ 🌐 English ⚖ 435 KB

Antithrombotic treatment and the risk of

✍ Gorin, L.; Fauchier, L.; Nonin, E.; de Labriolle, A.; Haguenoer, K.; Cosnay, P.; 📂 Article 📅 2010 🏛 Schattauer 🌐 English ⚖ 336 KB

Percutaneous closure of the left atrial

✍ David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Ma 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 192 KB

Population pharmacokinetic analysis of t

✍ K.-H. LIESENFELD; T. LEHR; C. DANSIRIKUL; P. A. REILLY; S. J. CONNOLLY; M. D. EZ 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Population pharmacokinetic analysis of t

✍ J. P. PATEL; B. GREEN; R. K. PATEL; J. G. DAVIES; R. ARYA 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

900 Efficacy and safety of apixaban comp

✍ J. Ezekowitz; P. Dorian; C. Granger; J. Alexander; R. Lopes; M. Hanna; M. Gerald 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 72 KB